居家元认知自助疗法对心脏康复伴焦虑抑郁患者可行性的随机对照试验方案
本研究为单盲可行性随机对照试验,比较常规心脏康复与常规康复联合居家元认知自助疗法(Home-MCT)。对象为心脏康复转诊且HADS焦虑或抑郁亚量表≥8分的患者,计划至少随机108例,1:1分组,随访4和12个月,评估可接受性、可行性及为完整试验提供设计依据。
要点
- Home-MCT为居家自助格式的元认知疗法,附加于常规心脏康复。
- 入组标准为HADS焦虑和/或抑郁亚量表评分≥8分。
- 主要目的为评估可接受性、可行性并获取完整试验的设计参数。
核心结论
- 该可行性试验将评估居家元认知自助疗法对心脏康复伴焦虑抑郁患者的可接受性及完整试验设计的可行性。
研究设计与样本
- 单盲可行性随机对照试验,比较常规心脏康复与常规康复联合Home-MCT,嵌入经济与定性评估。
- 计划至少随机108例受试者,按1:1分配至干预组和对照组。
- 参与者从英国国家健康服务体系招募,基线及4、12个月随访评估。
关键数值与推荐
- 入组条件为转诊心脏康复且医院焦虑抑郁量表焦虑和/或抑郁亚量表评分≥8分。
- 干预为居家自助格式的元认知疗法联合常规心脏康复,对照为常规心脏康复。
临床怎么用
- 若可行,Home-MCT可作为一种附加于心脏康复的居家心理干预选项。
局限性
- 原文未报告试验结果,仅描述方案,无法评估疗效与成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anxiety and depression are common among patients attending cardiac rehabilitation services. Currently available pharmacological and psychological interventions have limited effectiveness in this population. There are presently no psychological interventions for anxiety and depression integrated into cardiac rehabilitation services despite emphasis in key UK National Health Service policy. A new treatment, metacognitive therapy, is highly effective at reducing anxiety and depression in mental health settings. The principal aims of the current study are (1) to evaluate the acceptability of delivering metacognitive therapy in a home-based self-help format (Home-MCT) to cardiac rehabilitation patients experiencing anxiety and depressive symptoms and conduct a feasibility trial of Home-MCT plus usual cardiac rehabilitation compared to usual cardiac rehabilitation; and (2) to inform the design and sample size for a full-scale trial. METHODS: The PATHWAY Home-MCT trial is a single-blind feasibility randomised controlled trial comparing usual cardiac rehabilitation (control) versus usual cardiac rehabilitation plus home-based self-help metacognitive therapy (intervention). Economic and qualitative evaluations will be embedded within the trial. Participants will be assessed at baseline and followed-up at 4 and 12 months. Patients who have been referred to cardiac rehabilitation programmes and have a score of ≥ 8 on the anxiety and/or depression subscales of the Hospital Anxiety and Depression Scale will be invited to take part in the study and written informed consent will be obtained. Participants will be recruited from the National Health Service in the UK. A minimum of 108 participants will be randomised to the intervention and control arms in a 1:1 ratio. DISCUSSION: The Home-MCT feasibility randomised controlled trial will provide evidence on the acceptability of delivering metacognitive therapy in a home-based self-help format for cardiac rehabilitation patients experiencing symptoms of anxiety and/or depression and on the feasibility and design of a full-scale trial. In addition, it will provide provisional point estimates, with appropriately wide measures of uncertainty, relating to the effectiveness and cost-effectiveness of the intervention. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03129282 , Submitted to Registry: 11 April 2017.
引用
- Wells A, McNicol K, Reeves D, et al. Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT). Trials. 2018. PMID: 30115112. doi:10.1186/s13063-018-2826-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。